| CTRI Number |
CTRI/2022/07/044351 [Registered on: 26/07/2022] Trial Registered Prospectively |
| Last Modified On: |
26/07/2022 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Dentistry |
| Study Design |
Randomized, Parallel Group, Placebo Controlled Trial |
|
Public Title of Study
|
To compare the effect of premedication on success of Local anesthesia in pulpal inflammation |
|
Scientific Title of Study
|
To evaluate the efficacy of premedication with non steriodal anti-inflammatory drugs, corticosteriods and placebo on success of inferior alveolar nerve block in achieving pulpal anaesthesia in symptomatic irreversible pulpitis-A randomized control double blinded study |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Geethanjali R |
| Designation |
Post graduation student |
| Affiliation |
Karpaga vinayaga institute of dental sciences |
| Address |
Karpaga vinayaga institute of dental sciences
Department of conservative dentistry and endodontics
medical girls hostel
Room no.F18
madhurathakam
chengalpettu
Kancheepuram TAMIL NADU 603308 India |
| Phone |
7708411919 |
| Fax |
|
| Email |
geety97@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Madhuram K |
| Designation |
Head of the department |
| Affiliation |
Karpaga vinayaga institute of dental sciences |
| Address |
Karpaga vinayaga institute of dental sciences
Department of conservative dentistry and endodontics
madhurathakam
chengalpettu
Kancheepuram TAMIL NADU 603308 India |
| Phone |
9962677450 |
| Fax |
|
| Email |
madhu_endo@yahoo.com |
|
Details of Contact Person Public Query
|
| Name |
Geethanjali R |
| Designation |
Post graduation student |
| Affiliation |
Karpaga vinayaga institute of dental sciences |
| Address |
Karpaga vinayaga institute of dental sciences
Department of conservative dentistry and endodontics
medical girls hostel
Room no.F18
madhurathakam
chengalpettu
Kancheepuram TAMIL NADU 603308 India |
| Phone |
7708411919 |
| Fax |
|
| Email |
geety97@gmail.com |
|
|
Source of Monetary or Material Support
|
| Karpaga vinayaga institute of dental sciences |
|
|
Primary Sponsor
|
| Name |
Geethanjali R |
| Address |
Karpaga vinayaga institute of dental sciences
medical ladies hostel
chengalpettu |
| Type of Sponsor |
Other [Self] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Geethanjali R |
karpaga vinayaga institute of dental sciences |
karpaga vinayaga institute of dental sciences
Department of conservative dentistry and endodontics
Room no.4
madhuranthakam
kancheepuram Kancheepuram TAMIL NADU |
7708411919
geety97@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional ethics committee karpaga vinayaga institute of dental sciences |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: R50-R69||General symptoms and signs, (2) ICD-10 Condition: K040||Pulpitis, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
oral piroxicam
Ketrolac Dt
oral prednisolone
oral dexamethasone
|
20 mg oral piroxicam
10mg oral Ketrolac Dt
5 mg oral prednisolone
1 mg oral dexamethasone.
The route of administration is oral and is given 1 hour prior to the treatment |
| Comparator Agent |
Placebo |
zincovit. The route of administration is oral and is given 1 hour prior to the treatment |
|
|
Inclusion Criteria
|
| Age From |
19.00 Year(s) |
| Age To |
45.00 Year(s) |
| Gender |
Both |
| Details |
1.Healthy individuals of age 19 to 45
2.Subjects participating in the study had first or second mandibular molar teeth with symptomatic irreversible pulpitis.
3.Patients with no systemic disease |
|
| ExclusionCriteria |
| Details |
1.Patients who are allergic or sensitive to local anesthesia and drugs used in this study
2.Pregnant or lactating women
3.Patients who had taken any analgesic medication in the preceding 12 hours before the treatment.
4.Patients with history of peptic ulcer
6.Patients not willing to provide informed consent |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Participant and Outcome Assessor Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| To evaluate the success rate of Inferior alveolar nerve block with use of premedications. |
1 hour
|
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| To evaluate the success rate of Inferior alveolar nerve block with use of premedications. |
at baseline
|
|
|
Target Sample Size
|
Total Sample Size="100" Sample Size from India="100"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 4 |
|
Date of First Enrollment (India)
|
01/09/2022 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
01/09/2022 |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="3" Days="0" |
|
Recruitment Status of Trial (Global)
|
Open to Recruitment |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
|
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
This study is a double blinded,randomized control study comparing the effect of premedication with two non steriodal anti inflammatory drugs; Piroxicam 20mg and Ketorolac 10mg and two corticosteroids - Dexamethasone 1mg and Prednisolone 5mg with a placebo Zincovit on success of inferior alveolar nerve block in symptomatic irreversible pulpitis. |